We are live on
!
Find out more
Plus Therapeutics
PSTV
PSTV
25 hedge funds and large institutions have $5.92M invested in Plus Therapeutics in 2025 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 9 increasing their positions, 1 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
800% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 1
120% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 5
66% more capital invested
Capital invested by funds: $3.57M → $5.92M (+$2.35M)
25% more funds holding
Funds holding: 20 → 25 (+5)
0.13% more ownership
Funds ownership: 0.21% → 0.34% (+0.13%)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
25
Holders Change
+5
Holders Change %
+25%
% of All Funds
0.3%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
11
Increased
9
Reduced
1
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
BlackRock
New York
|
+$788K |
| 2 |
Jane Street
New York
|
+$618K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$502K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$356K |
| 5 |
VF
Virtu Financial
New York
|
+$300K |
